

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.88897576 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.79204328 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.77751923 |
| 4 | vocalization behavior (GO:0071625) | 5.68150260 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.52193471 |
| 6 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.42005795 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.41693699 |
| 8 | neuronal action potential propagation (GO:0019227) | 5.30059444 |
| 9 | synaptic vesicle maturation (GO:0016188) | 5.25907475 |
| 10 | glutamate secretion (GO:0014047) | 5.21547767 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.20674489 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.02561471 |
| 13 | glutamate receptor signaling pathway (GO:0007215) | 5.00210091 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.91918292 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.90934492 |
| 16 | protein localization to synapse (GO:0035418) | 4.88291433 |
| 17 | synaptic transmission, glutamatergic (GO:0035249) | 4.76495485 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 4.76466230 |
| 19 | exploration behavior (GO:0035640) | 4.54156450 |
| 20 | neuron-neuron synaptic transmission (GO:0007270) | 4.52521857 |
| 21 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.51151096 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.47797130 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 4.42172565 |
| 24 | neurotransmitter secretion (GO:0007269) | 4.35955323 |
| 25 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.34844871 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.24933622 |
| 27 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.24912458 |
| 28 | long-term memory (GO:0007616) | 4.23174090 |
| 29 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.21548546 |
| 30 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.06441123 |
| 31 | gamma-aminobutyric acid transport (GO:0015812) | 4.02882757 |
| 32 | positive regulation of synapse maturation (GO:0090129) | 4.02233432 |
| 33 | regulation of postsynaptic membrane potential (GO:0060078) | 4.00652139 |
| 34 | cellular potassium ion homeostasis (GO:0030007) | 3.96107443 |
| 35 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.95128360 |
| 36 | positive regulation of membrane potential (GO:0045838) | 3.91312915 |
| 37 | cerebellar granule cell differentiation (GO:0021707) | 3.90525973 |
| 38 | regulation of synapse structural plasticity (GO:0051823) | 3.86267450 |
| 39 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.84735929 |
| 40 | long-term synaptic potentiation (GO:0060291) | 3.84366953 |
| 41 | presynaptic membrane assembly (GO:0097105) | 3.81056514 |
| 42 | dendritic spine morphogenesis (GO:0060997) | 3.79848401 |
| 43 | regulation of synaptic plasticity (GO:0048167) | 3.79135367 |
| 44 | neuron recognition (GO:0008038) | 3.66563793 |
| 45 | transmission of nerve impulse (GO:0019226) | 3.66075792 |
| 46 | presynaptic membrane organization (GO:0097090) | 3.64487435 |
| 47 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.64302942 |
| 48 | layer formation in cerebral cortex (GO:0021819) | 3.63915009 |
| 49 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.63636716 |
| 50 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.60433869 |
| 51 | neurotransmitter transport (GO:0006836) | 3.60307043 |
| 52 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.59445032 |
| 53 | serotonin metabolic process (GO:0042428) | 3.59157915 |
| 54 | postsynaptic membrane organization (GO:0001941) | 3.56127142 |
| 55 | synaptic vesicle endocytosis (GO:0048488) | 3.52369345 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.51562983 |
| 57 | behavioral response to nicotine (GO:0035095) | 3.51065248 |
| 58 | axon ensheathment in central nervous system (GO:0032291) | 3.49570441 |
| 59 | central nervous system myelination (GO:0022010) | 3.49570441 |
| 60 | response to histamine (GO:0034776) | 3.49011328 |
| 61 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.43518654 |
| 62 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.40077179 |
| 63 | membrane depolarization (GO:0051899) | 3.39736811 |
| 64 | axonal fasciculation (GO:0007413) | 3.39227598 |
| 65 | neuromuscular process controlling balance (GO:0050885) | 3.35224250 |
| 66 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.34563324 |
| 67 | behavioral defense response (GO:0002209) | 3.34239290 |
| 68 | behavioral fear response (GO:0001662) | 3.34239290 |
| 69 | primary amino compound metabolic process (GO:1901160) | 3.34220073 |
| 70 | regulation of neurotransmitter levels (GO:0001505) | 3.32389023 |
| 71 | sodium ion export (GO:0071436) | 3.32210208 |
| 72 | regulation of vesicle fusion (GO:0031338) | 3.31030399 |
| 73 | neuromuscular synaptic transmission (GO:0007274) | 3.28801976 |
| 74 | long term synaptic depression (GO:0060292) | 3.27406460 |
| 75 | proline transport (GO:0015824) | 3.27329634 |
| 76 | fear response (GO:0042596) | 3.25688192 |
| 77 | potassium ion import (GO:0010107) | 3.25563951 |
| 78 | regulation of neurotransmitter transport (GO:0051588) | 3.22928206 |
| 79 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.21231321 |
| 80 | regulation of dendritic spine development (GO:0060998) | 3.21092622 |
| 81 | membrane depolarization during action potential (GO:0086010) | 3.20711029 |
| 82 | learning (GO:0007612) | 3.20415656 |
| 83 | auditory behavior (GO:0031223) | 3.20327446 |
| 84 | mechanosensory behavior (GO:0007638) | 3.20110878 |
| 85 | regulation of synapse maturation (GO:0090128) | 3.18721337 |
| 86 | membrane hyperpolarization (GO:0060081) | 3.18303009 |
| 87 | positive regulation of neurotransmitter transport (GO:0051590) | 3.17148661 |
| 88 | innervation (GO:0060384) | 3.16736878 |
| 89 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.15484146 |
| 90 | neuromuscular process controlling posture (GO:0050884) | 3.14945617 |
| 91 | activation of protein kinase A activity (GO:0034199) | 3.14626726 |
| 92 | L-amino acid import (GO:0043092) | 3.12855082 |
| 93 | startle response (GO:0001964) | 3.12456540 |
| 94 | regulation of synaptic transmission (GO:0050804) | 3.11905332 |
| 95 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.10859231 |
| 96 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.10237044 |
| 97 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.09782827 |
| 98 | synaptic transmission (GO:0007268) | 3.09672170 |
| 99 | positive regulation of synaptic transmission (GO:0050806) | 3.08632673 |
| 100 | positive regulation of dendritic spine development (GO:0060999) | 3.07954255 |
| 101 | neuronal action potential (GO:0019228) | 3.07915399 |
| 102 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.07842629 |
| 103 | behavioral response to cocaine (GO:0048148) | 3.07085625 |
| 104 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.06190473 |
| 105 | synapse assembly (GO:0007416) | 3.04682564 |
| 106 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.03933306 |
| 107 | dendritic spine organization (GO:0097061) | 3.02843713 |
| 108 | potassium ion transmembrane transport (GO:0071805) | 3.00561234 |
| 109 | cellular potassium ion transport (GO:0071804) | 3.00561234 |
| 110 | neuromuscular process (GO:0050905) | 3.00114673 |
| 111 | nucleobase catabolic process (GO:0046113) | 2.99376334 |
| 112 | neurotransmitter uptake (GO:0001504) | 2.99328639 |
| 113 | response to auditory stimulus (GO:0010996) | 2.99154491 |
| 114 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.98010630 |
| 115 | adult walking behavior (GO:0007628) | 2.97781194 |
| 116 | C4-dicarboxylate transport (GO:0015740) | 2.94645607 |
| 117 | detection of calcium ion (GO:0005513) | 2.91685343 |
| 118 | neuronal ion channel clustering (GO:0045161) | 2.91526440 |
| 119 | potassium ion homeostasis (GO:0055075) | 2.90793175 |
| 120 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.86839691 |
| 121 | cochlea development (GO:0090102) | 2.85644911 |
| 122 | potassium ion transport (GO:0006813) | 2.79145503 |
| 123 | regulation of neurotransmitter uptake (GO:0051580) | 2.76032463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.29047609 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.89538376 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.20119480 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.15950418 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.14928852 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.75398878 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.75398878 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.70164486 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.69021293 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60957949 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.57716006 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.52440145 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.52009132 |
| 14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.48765698 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45589094 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.44663686 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.42521341 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.37045470 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17858782 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.17719899 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.17711060 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.14988204 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13209248 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.98002537 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.95616899 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91945202 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86026043 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.84358985 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.82440520 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.80241722 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.79215398 |
| 32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.77198237 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.76990407 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.71995143 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.68124135 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.54337594 |
| 37 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.51642748 |
| 38 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51639077 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50399460 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42886469 |
| 41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40694410 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39259092 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38408271 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37589086 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37359217 |
| 46 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32828339 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32705825 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32639371 |
| 49 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31755606 |
| 50 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31499275 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.31130979 |
| 52 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31045446 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29308116 |
| 54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29101162 |
| 55 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.28766258 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28509700 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27202326 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25759141 |
| 59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.25395682 |
| 60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.25305402 |
| 61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24078023 |
| 62 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.22539481 |
| 63 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22320839 |
| 64 | AR_19668381_ChIP-Seq_PC3_Human | 1.19419396 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18321425 |
| 66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17759672 |
| 67 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17371387 |
| 68 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16118707 |
| 69 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15510977 |
| 70 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11745684 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09957641 |
| 72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09502655 |
| 73 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09495685 |
| 74 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.08938907 |
| 75 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08612626 |
| 76 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07852734 |
| 77 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07778426 |
| 78 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07778426 |
| 79 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06790361 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06090352 |
| 81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.05934222 |
| 82 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04428638 |
| 83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04372225 |
| 84 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03709650 |
| 85 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03544565 |
| 86 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03268244 |
| 87 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02881297 |
| 88 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02405107 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02383030 |
| 90 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02285061 |
| 91 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02136168 |
| 92 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01597859 |
| 93 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.00902481 |
| 94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00877986 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00805093 |
| 96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00499016 |
| 97 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99255525 |
| 98 | EWS_26573619_Chip-Seq_HEK293_Human | 0.98048665 |
| 99 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97989124 |
| 100 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97617296 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97602873 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97526748 |
| 103 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96825517 |
| 104 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96156125 |
| 105 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96156125 |
| 106 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.95711080 |
| 107 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.95711080 |
| 108 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95037720 |
| 109 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94943784 |
| 110 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94873244 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93611294 |
| 112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93314583 |
| 113 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92910299 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92815847 |
| 115 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91386869 |
| 116 | JUN_21703547_ChIP-Seq_K562_Human | 0.90703340 |
| 117 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90390699 |
| 118 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88180595 |
| 119 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88131352 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87544732 |
| 121 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.86804709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.68860531 |
| 2 | MP0003880_abnormal_central_pattern | 5.37243709 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.32181796 |
| 4 | MP0004270_analgesia | 3.73241397 |
| 5 | MP0009745_abnormal_behavioral_response | 3.64578760 |
| 6 | MP0009046_muscle_twitch | 3.47326815 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.44283785 |
| 8 | MP0002064_seizures | 3.35717509 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.18110243 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.97050256 |
| 11 | MP0002272_abnormal_nervous_system | 2.85715128 |
| 12 | MP0001486_abnormal_startle_reflex | 2.64503453 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.58757118 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.56583880 |
| 15 | MP0002736_abnormal_nociception_after | 2.52997913 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.52610990 |
| 17 | MP0002822_catalepsy | 2.40054532 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.34799426 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.33547493 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.16785547 |
| 21 | MP0008569_lethality_at_weaning | 2.12912342 |
| 22 | MP0001970_abnormal_pain_threshold | 1.90433636 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.89584479 |
| 24 | MP0002184_abnormal_innervation | 1.82745747 |
| 25 | MP0003329_amyloid_beta_deposits | 1.80699635 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.80227560 |
| 27 | MP0004924_abnormal_behavior | 1.75816632 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.75816632 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.75400078 |
| 30 | MP0000778_abnormal_nervous_system | 1.71563390 |
| 31 | MP0003879_abnormal_hair_cell | 1.67875129 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.59068579 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.58770867 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.56850831 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.46882202 |
| 36 | MP0001984_abnormal_olfaction | 1.46782686 |
| 37 | MP0000955_abnormal_spinal_cord | 1.46690305 |
| 38 | MP0002066_abnormal_motor_capabilities/c | 1.45913115 |
| 39 | MP0003787_abnormal_imprinting | 1.45866782 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.45766842 |
| 41 | MP0004858_abnormal_nervous_system | 1.44429340 |
| 42 | MP0003136_yellow_coat_color | 1.41417614 |
| 43 | MP0004147_increased_porphyrin_level | 1.40533075 |
| 44 | MP0003633_abnormal_nervous_system | 1.39802012 |
| 45 | MP0004885_abnormal_endolymph | 1.39517460 |
| 46 | MP0002882_abnormal_neuron_morphology | 1.37734305 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.37237693 |
| 48 | MP0004142_abnormal_muscle_tone | 1.35173855 |
| 49 | MP0001188_hyperpigmentation | 1.33128391 |
| 50 | MP0001529_abnormal_vocalization | 1.32300387 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.25893761 |
| 52 | MP0001905_abnormal_dopamine_level | 1.25493245 |
| 53 | MP0002653_abnormal_ependyma_morphology | 1.21827277 |
| 54 | MP0003631_nervous_system_phenotype | 1.21357304 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.17641558 |
| 56 | MP0004742_abnormal_vestibular_system | 1.13681175 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.13184925 |
| 58 | MP0006072_abnormal_retinal_apoptosis | 1.12049330 |
| 59 | MP0008872_abnormal_physiological_respon | 1.08235169 |
| 60 | MP0002152_abnormal_brain_morphology | 1.08060426 |
| 61 | MP0003121_genomic_imprinting | 1.04606509 |
| 62 | MP0002229_neurodegeneration | 0.99067936 |
| 63 | MP0005253_abnormal_eye_physiology | 0.98525049 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 0.97720127 |
| 65 | MP0000920_abnormal_myelination | 0.95224838 |
| 66 | MP0003283_abnormal_digestive_organ | 0.95020693 |
| 67 | MP0002102_abnormal_ear_morphology | 0.94292945 |
| 68 | MP0008874_decreased_physiological_sensi | 0.93626255 |
| 69 | MP0010386_abnormal_urinary_bladder | 0.92740928 |
| 70 | MP0001963_abnormal_hearing_physiology | 0.92265705 |
| 71 | MP0003122_maternal_imprinting | 0.91576630 |
| 72 | MP0003632_abnormal_nervous_system | 0.91276956 |
| 73 | MP0002069_abnormal_eating/drinking_beha | 0.90965285 |
| 74 | MP0003690_abnormal_glial_cell | 0.89966038 |
| 75 | MP0000751_myopathy | 0.89413459 |
| 76 | MP0003195_calcinosis | 0.88778547 |
| 77 | MP0003890_abnormal_embryonic-extraembry | 0.86977506 |
| 78 | MP0001177_atelectasis | 0.85280339 |
| 79 | MP0004484_altered_response_of | 0.83071698 |
| 80 | MP0004085_abnormal_heartbeat | 0.81690546 |
| 81 | MP0005409_darkened_coat_color | 0.81527855 |
| 82 | MP0005535_abnormal_body_temperature | 0.80761726 |
| 83 | MP0004215_abnormal_myocardial_fiber | 0.80036347 |
| 84 | MP0001485_abnormal_pinna_reflex | 0.79587502 |
| 85 | MP0004133_heterotaxia | 0.77954006 |
| 86 | MP0002837_dystrophic_cardiac_calcinosis | 0.77580425 |
| 87 | MP0006292_abnormal_olfactory_placode | 0.77415296 |
| 88 | MP0000604_amyloidosis | 0.76680516 |
| 89 | MP0003123_paternal_imprinting | 0.76068566 |
| 90 | MP0003075_altered_response_to | 0.75260210 |
| 91 | MP0003634_abnormal_glial_cell | 0.75046785 |
| 92 | MP0000013_abnormal_adipose_tissue | 0.73101283 |
| 93 | MP0005174_abnormal_tail_pigmentation | 0.72566558 |
| 94 | MP0002752_abnormal_somatic_nervous | 0.72386926 |
| 95 | MP0003045_fibrosis | 0.72065207 |
| 96 | MP0002234_abnormal_pharynx_morphology | 0.71214549 |
| 97 | MP0000569_abnormal_digit_pigmentation | 0.70431267 |
| 98 | MP0004510_myositis | 0.70369418 |
| 99 | MP0002876_abnormal_thyroid_physiology | 0.68647934 |
| 100 | MP0000631_abnormal_neuroendocrine_gland | 0.68106593 |
| 101 | MP0005394_taste/olfaction_phenotype | 0.67238789 |
| 102 | MP0005499_abnormal_olfactory_system | 0.67238789 |
| 103 | MP0003646_muscle_fatigue | 0.66481602 |
| 104 | MP0005171_absent_coat_pigmentation | 0.64863359 |
| 105 | MP0001664_abnormal_digestion | 0.63176785 |
| 106 | MP0004043_abnormal_pH_regulation | 0.63034529 |
| 107 | MP0002928_abnormal_bile_duct | 0.61633363 |
| 108 | MP0002090_abnormal_vision | 0.60450387 |
| 109 | MP0003137_abnormal_impulse_conducting | 0.60086077 |
| 110 | MP0002160_abnormal_reproductive_system | 0.59105224 |
| 111 | MP0000427_abnormal_hair_cycle | 0.57365784 |
| 112 | MP0005187_abnormal_penis_morphology | 0.57136247 |
| 113 | MP0002751_abnormal_autonomic_nervous | 0.56900598 |
| 114 | MP0001943_abnormal_respiration | 0.54867006 |
| 115 | MP0000026_abnormal_inner_ear | 0.53458848 |
| 116 | MP0010769_abnormal_survival | 0.53159561 |
| 117 | MP0002638_abnormal_pupillary_reflex | 0.51796327 |
| 118 | MP0010770_preweaning_lethality | 0.51144010 |
| 119 | MP0002082_postnatal_lethality | 0.51144010 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.51016740 |
| 121 | MP0004233_abnormal_muscle_weight | 0.50551437 |
| 122 | MP0010768_mortality/aging | 0.50177854 |
| 123 | MP0005623_abnormal_meninges_morphology | 0.49781032 |
| 124 | MP0003956_abnormal_body_size | 0.49190675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.97158378 |
| 2 | Myokymia (HP:0002411) | 6.63682425 |
| 3 | Focal seizures (HP:0007359) | 6.24994436 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.60911463 |
| 5 | Atonic seizures (HP:0010819) | 5.40120322 |
| 6 | Visual hallucinations (HP:0002367) | 5.28929252 |
| 7 | Febrile seizures (HP:0002373) | 5.01960047 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.88833999 |
| 9 | Absence seizures (HP:0002121) | 4.72447290 |
| 10 | Hyperventilation (HP:0002883) | 4.37202911 |
| 11 | Dialeptic seizures (HP:0011146) | 4.35871175 |
| 12 | Broad-based gait (HP:0002136) | 4.31723354 |
| 13 | Action tremor (HP:0002345) | 4.30649207 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 4.21393196 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 4.12025752 |
| 16 | Poor eye contact (HP:0000817) | 3.67798435 |
| 17 | Limb dystonia (HP:0002451) | 3.67344676 |
| 18 | Dysdiadochokinesis (HP:0002075) | 3.65946050 |
| 19 | Dysmetria (HP:0001310) | 3.51853387 |
| 20 | Truncal ataxia (HP:0002078) | 3.38296549 |
| 21 | Scanning speech (HP:0002168) | 3.33659476 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 3.26548576 |
| 23 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.26341596 |
| 24 | Abnormal social behavior (HP:0012433) | 3.25829873 |
| 25 | Impaired social interactions (HP:0000735) | 3.25829873 |
| 26 | Impaired smooth pursuit (HP:0007772) | 3.20690561 |
| 27 | Amblyopia (HP:0000646) | 3.18895025 |
| 28 | Anxiety (HP:0000739) | 3.04310803 |
| 29 | Depression (HP:0000716) | 3.02622250 |
| 30 | Excessive salivation (HP:0003781) | 2.94012378 |
| 31 | Drooling (HP:0002307) | 2.94012378 |
| 32 | Hemiparesis (HP:0001269) | 2.92242623 |
| 33 | Dysmetric saccades (HP:0000641) | 2.85682263 |
| 34 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.83491011 |
| 35 | Abnormal eating behavior (HP:0100738) | 2.80809173 |
| 36 | Genetic anticipation (HP:0003743) | 2.79316267 |
| 37 | Abnormality of binocular vision (HP:0011514) | 2.79172728 |
| 38 | Diplopia (HP:0000651) | 2.79172728 |
| 39 | Absent speech (HP:0001344) | 2.78857628 |
| 40 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.76553795 |
| 41 | Ankle clonus (HP:0011448) | 2.76117886 |
| 42 | Postural instability (HP:0002172) | 2.74561188 |
| 43 | Pancreatic cysts (HP:0001737) | 2.72358729 |
| 44 | Intention tremor (HP:0002080) | 2.69635944 |
| 45 | Epileptiform EEG discharges (HP:0011182) | 2.67417411 |
| 46 | Abnormality of the lower motor neuron (HP:0002366) | 2.66093973 |
| 47 | Stereotypic behavior (HP:0000733) | 2.62128391 |
| 48 | Cerebral inclusion bodies (HP:0100314) | 2.58630149 |
| 49 | Status epilepticus (HP:0002133) | 2.57863524 |
| 50 | Neurofibrillary tangles (HP:0002185) | 2.57487711 |
| 51 | Hemiplegia (HP:0002301) | 2.56788472 |
| 52 | Progressive inability to walk (HP:0002505) | 2.52564076 |
| 53 | Spastic gait (HP:0002064) | 2.45436597 |
| 54 | Nephronophthisis (HP:0000090) | 2.44749342 |
| 55 | Mutism (HP:0002300) | 2.44040956 |
| 56 | Fetal akinesia sequence (HP:0001989) | 2.43786862 |
| 57 | Type II lissencephaly (HP:0007260) | 2.42740136 |
| 58 | EEG with generalized epileptiform discharges (HP:0011198) | 2.42688419 |
| 59 | Urinary urgency (HP:0000012) | 2.40562350 |
| 60 | Gait imbalance (HP:0002141) | 2.38578096 |
| 61 | Pancreatic fibrosis (HP:0100732) | 2.38347735 |
| 62 | Congenital stationary night blindness (HP:0007642) | 2.38025438 |
| 63 | Inability to walk (HP:0002540) | 2.33821835 |
| 64 | Bradykinesia (HP:0002067) | 2.31120597 |
| 65 | Impaired vibratory sensation (HP:0002495) | 2.28813852 |
| 66 | Abnormality of the corticospinal tract (HP:0002492) | 2.28298627 |
| 67 | True hermaphroditism (HP:0010459) | 2.26774377 |
| 68 | Papilledema (HP:0001085) | 2.24261796 |
| 69 | Protruding tongue (HP:0010808) | 2.23850607 |
| 70 | Hypsarrhythmia (HP:0002521) | 2.23434544 |
| 71 | Generalized myoclonic seizures (HP:0002123) | 2.23186838 |
| 72 | Medial flaring of the eyebrow (HP:0010747) | 2.21321418 |
| 73 | Blue irides (HP:0000635) | 2.21293828 |
| 74 | Molar tooth sign on MRI (HP:0002419) | 2.21209084 |
| 75 | Abnormality of midbrain morphology (HP:0002418) | 2.21209084 |
| 76 | Insidious onset (HP:0003587) | 2.18400532 |
| 77 | Termporal pattern (HP:0011008) | 2.18400532 |
| 78 | Gait ataxia (HP:0002066) | 2.16722557 |
| 79 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.16533589 |
| 80 | Torticollis (HP:0000473) | 2.13997883 |
| 81 | Focal dystonia (HP:0004373) | 2.12596569 |
| 82 | Annular pancreas (HP:0001734) | 2.09857738 |
| 83 | Abnormality of the renal medulla (HP:0100957) | 2.08242097 |
| 84 | Akinesia (HP:0002304) | 2.05084827 |
| 85 | Incomplete penetrance (HP:0003829) | 2.03883466 |
| 86 | Ventricular fibrillation (HP:0001663) | 2.02872806 |
| 87 | Abnormality of salivation (HP:0100755) | 2.02317799 |
| 88 | Prolonged QT interval (HP:0001657) | 2.00083087 |
| 89 | Abnormal drinking behavior (HP:0030082) | 1.99499595 |
| 90 | Polydipsia (HP:0001959) | 1.99499595 |
| 91 | Abnormality of saccadic eye movements (HP:0000570) | 1.97944578 |
| 92 | Megalencephaly (HP:0001355) | 1.95320502 |
| 93 | Psychosis (HP:0000709) | 1.95021795 |
| 94 | Lower limb muscle weakness (HP:0007340) | 1.94209451 |
| 95 | Lissencephaly (HP:0001339) | 1.93720875 |
| 96 | Spastic tetraplegia (HP:0002510) | 1.91023066 |
| 97 | Cystic liver disease (HP:0006706) | 1.90617987 |
| 98 | Pheochromocytoma (HP:0002666) | 1.89468180 |
| 99 | Cerebral hypomyelination (HP:0006808) | 1.87685531 |
| 100 | Sleep apnea (HP:0010535) | 1.86659382 |
| 101 | Delusions (HP:0000746) | 1.85169920 |
| 102 | Lower limb asymmetry (HP:0100559) | 1.85140139 |
| 103 | Abnormality of the renal cortex (HP:0011035) | 1.83217964 |
| 104 | Ulnar claw (HP:0001178) | 1.80687777 |
| 105 | Polyphagia (HP:0002591) | 1.79871658 |
| 106 | Spastic tetraparesis (HP:0001285) | 1.79285205 |
| 107 | Neuronal loss in central nervous system (HP:0002529) | 1.78865892 |
| 108 | Inappropriate behavior (HP:0000719) | 1.78245101 |
| 109 | Amyotrophic lateral sclerosis (HP:0007354) | 1.78101900 |
| 110 | Neuroendocrine neoplasm (HP:0100634) | 1.77714538 |
| 111 | Congenital primary aphakia (HP:0007707) | 1.77322014 |
| 112 | Craniofacial dystonia (HP:0012179) | 1.76185043 |
| 113 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.75650597 |
| 114 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.75650597 |
| 115 | Thickened helices (HP:0000391) | 1.75469081 |
| 116 | CNS hypomyelination (HP:0003429) | 1.75278037 |
| 117 | Limb ataxia (HP:0002070) | 1.74341496 |
| 118 | Optic nerve hypoplasia (HP:0000609) | 1.73064553 |
| 119 | Agitation (HP:0000713) | 1.72924866 |
| 120 | Generalized hypopigmentation of hair (HP:0011358) | 1.72913245 |
| 121 | Increased circulating renin level (HP:0000848) | 1.72746628 |
| 122 | Obstructive sleep apnea (HP:0002870) | 1.72645264 |
| 123 | Syncope (HP:0001279) | 1.72415331 |
| 124 | Hypomagnesemia (HP:0002917) | 1.72219093 |
| 125 | Pachygyria (HP:0001302) | 1.72175715 |
| 126 | Abnormal EKG (HP:0003115) | 1.72087027 |
| 127 | Horizontal nystagmus (HP:0000666) | 1.71758985 |
| 128 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.71102024 |
| 129 | Hypothermia (HP:0002045) | 1.71039168 |
| 130 | Retinal dysplasia (HP:0007973) | 1.71027701 |
| 131 | Cerebellar dysplasia (HP:0007033) | 1.70446603 |
| 132 | Widely spaced teeth (HP:0000687) | 1.70385956 |
| 133 | Pointed chin (HP:0000307) | 1.70123754 |
| 134 | Clumsiness (HP:0002312) | 1.70104462 |
| 135 | Postural tremor (HP:0002174) | 1.68413092 |
| 136 | Specific learning disability (HP:0001328) | 1.64966374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.83121784 |
| 2 | NTRK3 | 4.78473485 |
| 3 | FRK | 3.22131172 |
| 4 | MAP3K9 | 3.14362173 |
| 5 | MAP3K4 | 2.99692464 |
| 6 | RIPK4 | 2.89788302 |
| 7 | CASK | 2.85780773 |
| 8 | DAPK2 | 2.67896193 |
| 9 | MAP2K7 | 2.67232899 |
| 10 | MINK1 | 2.42845778 |
| 11 | MARK1 | 2.17864713 |
| 12 | MAP3K12 | 2.14966706 |
| 13 | PAK6 | 2.03295968 |
| 14 | MAP2K4 | 1.98692667 |
| 15 | CDK19 | 1.94010830 |
| 16 | NTRK2 | 1.86195997 |
| 17 | DAPK1 | 1.85090436 |
| 18 | PNCK | 1.82530870 |
| 19 | CAMKK1 | 1.78649364 |
| 20 | KSR2 | 1.77436049 |
| 21 | BMPR1B | 1.67575826 |
| 22 | PLK2 | 1.66553238 |
| 23 | TNIK | 1.66469853 |
| 24 | CAMKK2 | 1.60453477 |
| 25 | STK38L | 1.60279463 |
| 26 | NTRK1 | 1.59716240 |
| 27 | ADRBK2 | 1.58027355 |
| 28 | PRPF4B | 1.55156988 |
| 29 | WNK3 | 1.52222935 |
| 30 | KSR1 | 1.49792255 |
| 31 | CDK5 | 1.48153621 |
| 32 | PRKD3 | 1.45470139 |
| 33 | GRK5 | 1.37231722 |
| 34 | BMPR2 | 1.35348732 |
| 35 | PRKCG | 1.32687331 |
| 36 | STK38 | 1.28748100 |
| 37 | SIK2 | 1.25150414 |
| 38 | WNK4 | 1.24793652 |
| 39 | OXSR1 | 1.23853716 |
| 40 | LATS1 | 1.23544434 |
| 41 | FES | 1.21843707 |
| 42 | ACVR1B | 1.21807941 |
| 43 | MAPK13 | 1.21177202 |
| 44 | ARAF | 1.18627574 |
| 45 | CAMK2A | 1.15872004 |
| 46 | MAP3K13 | 1.13604826 |
| 47 | CAMK2B | 1.12777555 |
| 48 | PTK2B | 1.01970392 |
| 49 | CAMK1 | 0.99644314 |
| 50 | SGK223 | 0.96716668 |
| 51 | SGK494 | 0.96716668 |
| 52 | FGFR2 | 0.96274460 |
| 53 | GRK1 | 0.95714850 |
| 54 | TYRO3 | 0.95452187 |
| 55 | MAP3K2 | 0.93793144 |
| 56 | DYRK2 | 0.93664337 |
| 57 | UHMK1 | 0.92919684 |
| 58 | MAP4K2 | 0.88640040 |
| 59 | ZAK | 0.88114558 |
| 60 | SGK2 | 0.87586780 |
| 61 | CDK18 | 0.87475401 |
| 62 | CCNB1 | 0.87289175 |
| 63 | CDK15 | 0.85048262 |
| 64 | STK11 | 0.84623366 |
| 65 | RAF1 | 0.83525261 |
| 66 | TAOK3 | 0.81866299 |
| 67 | CDK14 | 0.80742494 |
| 68 | INSRR | 0.79953107 |
| 69 | SGK1 | 0.77834811 |
| 70 | PINK1 | 0.74620255 |
| 71 | CDK11A | 0.73683515 |
| 72 | TLK1 | 0.70690576 |
| 73 | AKT3 | 0.70310090 |
| 74 | DYRK1A | 0.69109061 |
| 75 | NME1 | 0.68287700 |
| 76 | PDK1 | 0.68166026 |
| 77 | PKN1 | 0.68157317 |
| 78 | PRKCH | 0.65721045 |
| 79 | SGK3 | 0.65356494 |
| 80 | MKNK2 | 0.65123337 |
| 81 | WNK1 | 0.65041570 |
| 82 | TNK2 | 0.64520928 |
| 83 | CAMK2D | 0.63538525 |
| 84 | ADRBK1 | 0.63126467 |
| 85 | RET | 0.61866835 |
| 86 | PDPK1 | 0.61136281 |
| 87 | FGR | 0.61018068 |
| 88 | TAOK1 | 0.60702454 |
| 89 | TRIM28 | 0.59800530 |
| 90 | CAMK2G | 0.59304562 |
| 91 | NEK6 | 0.59167020 |
| 92 | CSNK1A1L | 0.58231682 |
| 93 | PAK3 | 0.55639274 |
| 94 | PRKCE | 0.54844308 |
| 95 | PHKG2 | 0.54617665 |
| 96 | PHKG1 | 0.54617665 |
| 97 | CSNK1G3 | 0.53315575 |
| 98 | MARK2 | 0.52197147 |
| 99 | PIK3CA | 0.51544240 |
| 100 | CSNK1G2 | 0.51368348 |
| 101 | MAP2K6 | 0.50833936 |
| 102 | CAMK4 | 0.48385644 |
| 103 | PRKACA | 0.48000221 |
| 104 | CAMK1G | 0.47592953 |
| 105 | CSNK1D | 0.47194790 |
| 106 | MAP3K1 | 0.47180406 |
| 107 | RPS6KA3 | 0.46893291 |
| 108 | CSNK1G1 | 0.45697805 |
| 109 | MUSK | 0.44789414 |
| 110 | LATS2 | 0.43977334 |
| 111 | FYN | 0.43543012 |
| 112 | ROCK2 | 0.42898496 |
| 113 | MAPKAPK5 | 0.42748395 |
| 114 | MAPK10 | 0.41781471 |
| 115 | SIK3 | 0.41385798 |
| 116 | PRKG1 | 0.41176433 |
| 117 | FER | 0.40844095 |
| 118 | ALK | 0.40615159 |
| 119 | PRKCZ | 0.40040503 |
| 120 | PRKCA | 0.39318721 |
| 121 | MAP3K7 | 0.39311617 |
| 122 | DAPK3 | 0.38906788 |
| 123 | MAP3K6 | 0.37540167 |
| 124 | MAPK12 | 0.37464537 |
| 125 | BCR | 0.37097584 |
| 126 | DMPK | 0.37003175 |
| 127 | CSNK1A1 | 0.36729471 |
| 128 | STK39 | 0.36599564 |
| 129 | MAP2K1 | 0.34971769 |
| 130 | GRK7 | 0.34900588 |
| 131 | ERBB2 | 0.33498733 |
| 132 | NLK | 0.32365870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.26175492 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.09902748 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 3.05115580 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.94614177 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.85935900 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.84852326 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72707279 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.68383217 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.61677709 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.57543537 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.39759796 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.16834109 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.10154848 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.03420494 |
| 15 | Long-term depression_Homo sapiens_hsa04730 | 1.99881702 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.97948764 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.97366180 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.87682105 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.84589800 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.80637253 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.75723769 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.74456084 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.72403867 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60662668 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.53876362 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.48246334 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44532918 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41699620 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.37329194 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.33288315 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.32034789 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.30275423 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27392628 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.18436277 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.17788740 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13575814 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.12474496 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.12008701 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10044934 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08688275 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08281983 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 1.04113265 |
| 43 | Glioma_Homo sapiens_hsa05214 | 1.03943416 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.02703128 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.02552096 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 1.00554680 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00471344 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00205727 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98237043 |
| 50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96431867 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96205835 |
| 52 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.92734882 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87929183 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.86711745 |
| 55 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83967391 |
| 56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81097738 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80659517 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80018262 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79222636 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78559052 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73971278 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73687361 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72543533 |
| 64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69598947 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69253883 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67869765 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65764691 |
| 68 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64011747 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63186583 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62250636 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59847866 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59418451 |
| 73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59112762 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58449289 |
| 75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58241677 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.57249074 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55184053 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54570368 |
| 79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54458827 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53497562 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51348579 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50944406 |
| 83 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50863273 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49556522 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49488968 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.48443697 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47551270 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47528103 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45964750 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44408516 |
| 91 | Histidine metabolism_Homo sapiens_hsa00340 | 0.42329876 |
| 92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41853227 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41362837 |
| 94 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41301200 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.41167712 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.41052959 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39669709 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37218618 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36078417 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35909910 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.33691158 |
| 102 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.31882541 |
| 103 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.31209122 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31063201 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31008823 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30967229 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30006118 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29859077 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.29381208 |
| 110 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29009349 |
| 111 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.27955890 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27779962 |
| 113 | Huntingtons disease_Homo sapiens_hsa05016 | 0.27655893 |
| 114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27180515 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.25605407 |
| 116 | Protein export_Homo sapiens_hsa03060 | 0.24726133 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.24148410 |
| 118 | Peroxisome_Homo sapiens_hsa04146 | 0.23996690 |
| 119 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.23634378 |
| 120 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.23539442 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23083321 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22979485 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22958799 |
| 124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21587657 |

